Larite Industries Ltd.
| BSE: 512325 | Sector: Health care |
| NSE: N.A. | ISIN Code: N.A. |
| BSE 05:30 | 01 Jan | Larite Industries Ltd |
| NSE 05:30 | 01 Jan | Larite Industries Ltd |
Larite Industries Ltd. (LARITEINDS) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 903.95 | 0.38 | 966.90 | 652.75 | 216884.72 |
| Divi's Lab. | 3514.45 | 1.89 | 5425.00 | 3365.10 | 93291.08 |
| Cipla | 966.30 | 0.20 | 1083.15 | 850.00 | 77965.91 |
| Dr Reddy's Labs | 4392.00 | 1.97 | 5613.65 | 3655.00 | 73091.66 |
| Apollo Hospitals | 3861.60 | 5.28 | 5930.70 | 3122.90 | 55522.08 |
| Torrent Pharma. | 2939.85 | 1.34 | 3304.45 | 2485.00 | 49748.14 |
| Gland Pharma | 2906.70 | 1.87 | 4350.00 | 2679.00 | 47844.28 |
| Biocon | 333.25 | 2.43 | 420.25 | 314.90 | 40009.99 |
| Piramal Enterp. | 1644.90 | -11.37 | 3013.00 | 1632.25 | 39255.54 |
| Zydus Lifesci. | 373.65 | 0.21 | 668.85 | 319.40 | 38250.55 |
| Abbott India | 17950.15 | 1.42 | 23902.30 | 15525.00 | 38144.07 |
| Alkem Lab | 3042.05 | 0.59 | 4067.70 | 2835.00 | 36367.71 |
| Max Healthcare | 374.15 | 1.81 | 472.60 | 205.00 | 36278.71 |
| Aurobindo Pharma | 529.60 | -1.10 | 1038.30 | 514.50 | 31029.26 |
| Laurus Labs | 566.60 | 1.32 | 723.55 | 433.20 | 30446.25 |
| Lupin | 606.15 | 0.90 | 1267.50 | 583.05 | 27549.52 |
| Glaxosmi. Pharma | 1519.30 | 0.40 | 1917.00 | 1433.05 | 25738.46 |
| Ipca Labs. | 901.85 | -1.67 | 1383.55 | 899.00 | 22879.94 |
| Syngene Intl. | 531.10 | 0.70 | 699.95 | 508.10 | 21319.95 |
| Pfizer | 4269.00 | 0.50 | 6164.80 | 4077.80 | 19530.68 |
Quick Links for Larite Industries:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
